EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate


Uz B., BÜYÜKAŞIK Y., Atay H., Kelkitli E., Turgut M., Bektas Ö., ...Daha Fazla

HEMATOLOGY, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1179/1607845412y.0000000071
  • Dergi Adı: HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.247-252
  • Anahtar Kelimeler: Chronic myeloid leukemia, Imatinib mesylate, Sokal scoring system, Euro/Hasford scoring system, EUTOS CML scoring system, CHRONIC MYELOID-LEUKEMIA, INTERFERON, RISK
  • Karadeniz Teknik Üniversitesi Adresli: Hayır

Özet

Objectives: The validity of the three currently used chronic myeloid leukemia (CML) scoring systems (Sokal CML prognostic scoring system, Euro/Hasford CML scoring system, and the EUTOS CML prognostic scoring system) were compared in the CML patients receiving frontline imatinib mesylate.